Nikki Finke: Paul Rudd Is ‘Box Office Poison’

Paul Rudd‘s long run of getting every leading and supporting male roll in Hollywood – may have just come to an abrupt end as tinsel town prognosticator, Nikki Finkel, Deadline, just dubbed the actor “Box Office Poison.”Speaking about the dreadful open of the new Tina Fey flop, Admission, Finke, seemlingly speaking directly to Fey said,

Oh, Tina, Tina, Tina. You’re the funniest woman on the small screen in my opinion. But Red States may be holding a grudge over your SNL Sarah Palin impressions. And surely you can do better on the big screen than pairing with Paul since he’s box office poison.

 
Wow! Don’t mince any words Nikki! I’ll tell ya! You do not want to get up in the morning and find out you’ve just been ostracized by your peers! Or at least the peer to whom all of of Hollywood listens! But that must be the way Rudd is feeling after learning of his new coffin nail of a moniker which Finke wrote all over his ageless face! Thanks!

Here is the entire bit for your consumption…

Right now for #5 is Focus Features’ Tina Fey/Paul Rudd new low-budget comedy Admission (2,160 theaters) which grossed $2M Friday and $2.8M Saturday for as soft as $6.6M this weekend. Audiences gave it a mediocre ‘B-’ CinemaScore which didn’t help. Oh, Tina, Tina, Tina. You’re the funniest woman on the small screen in my opinion. But Red States may be holding a grudge over your SNL Sarah Palin impressions. And surely you can do better on the big screen than pairing with Paul since he’s box office poison. Pic underperformed studio expectations and barely met the low end of tracking. Even Focus admits grosses are soft despite its middling release and modest $13M cost. Because it’s a $30M-plus P&A pricetag just to open any pic these days. Focus saw a weekend that not only starts the waiting period for college acceptance letters but also had few moviegoing options for adult females aged 25+.